CY1119972T1 - Προσδιορισμος για αντισωματα ιου jc - Google Patents
Προσδιορισμος για αντισωματα ιου jcInfo
- Publication number
- CY1119972T1 CY1119972T1 CY20181100251T CY181100251T CY1119972T1 CY 1119972 T1 CY1119972 T1 CY 1119972T1 CY 20181100251 T CY20181100251 T CY 20181100251T CY 181100251 T CY181100251 T CY 181100251T CY 1119972 T1 CY1119972 T1 CY 1119972T1
- Authority
- CY
- Cyprus
- Prior art keywords
- sample
- subject
- jcv
- hpvlp
- antibody
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/01—DNA viruses
- G01N2333/025—Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2469/00—Immunoassays for the detection of microorganisms
- G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/50—Determining the risk of developing a disease
Abstract
Η αποκάλυψη αφορά μεθόδους και αντιδραστήρια και ανάλυση δειγμάτων για αντισώματα ιού JC. Αποκαλύπτεται μία μέθοδος που περιλαμβάνει λήψη ενός βιολογικού δείγματος από ένα υποκείμενο (π.χ., πλάσμα, ορός, αίμα, ούρα, ή εγκεφαλονωτιαίο υγρό), επαφή του δείγματος με εξαιρετικά καθαρισμένα virus-like σωματίδια (HPVLPs), υπό συνθήκες κατάλληλες για δέσμευση ενός αντισώματος JCV εντός του δείγματος προς ένα HPVLP και ανίχνευση του επιπέδου δέσμευσης αντισώματος JCV εντός του δείγματος προς ένα HPVLP. Σε μία υλοποίηση, ο ορισμός του επιπέδου αντισωμάτων έναντι JCV στο δείγμα του υποκειμένου παρέχει μία μέθοδο για την ταυτοποίηση κινδύνου PML σε ένα υποκείμενο.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US29404810P | 2010-01-11 | 2010-01-11 | |
US31619310P | 2010-03-22 | 2010-03-22 | |
PCT/US2011/020832 WO2011085369A1 (en) | 2010-01-11 | 2011-01-11 | Assay for jc virus antibodies |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1119972T1 true CY1119972T1 (el) | 2018-12-12 |
Family
ID=44305841
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20181100251T CY1119972T1 (el) | 2010-01-11 | 2018-02-28 | Προσδιορισμος για αντισωματα ιου jc |
CY20221100739T CY1126069T1 (el) | 2010-01-11 | 2022-11-18 | Προσδιορισμος για αντισωματα ιου jc |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20221100739T CY1126069T1 (el) | 2010-01-11 | 2022-11-18 | Προσδιορισμος για αντισωματα ιου jc |
Country Status (27)
Country | Link |
---|---|
US (2) | US9316641B2 (el) |
EP (3) | EP4152004A1 (el) |
JP (2) | JP5946218B2 (el) |
KR (1) | KR101877576B1 (el) |
CN (1) | CN102906278A (el) |
AU (1) | AU2011203815B2 (el) |
BR (1) | BR112012017014B1 (el) |
CA (1) | CA2784137A1 (el) |
CY (2) | CY1119972T1 (el) |
DK (2) | DK3339865T5 (el) |
ES (2) | ES2930469T3 (el) |
FI (1) | FI3339865T5 (el) |
HK (1) | HK1255318A1 (el) |
HR (2) | HRP20221390T1 (el) |
HU (2) | HUE060312T2 (el) |
IN (1) | IN2012DN06139A (el) |
LT (2) | LT2524060T (el) |
ME (1) | ME03026B (el) |
MX (1) | MX341991B (el) |
NO (1) | NO2524060T3 (el) |
NZ (1) | NZ600681A (el) |
PL (2) | PL3339865T3 (el) |
PT (2) | PT2524060T (el) |
RS (2) | RS63744B1 (el) |
SG (2) | SG181653A1 (el) |
SI (2) | SI3339865T1 (el) |
WO (1) | WO2011085369A1 (el) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL3264094T3 (pl) | 2005-04-04 | 2021-04-19 | Biogen Ma Inc. | Sposoby oceniania odpowiedzi immunologicznej na środek leczniczy |
JP2009528359A (ja) | 2006-02-28 | 2009-08-06 | エラン ファーマシューティカルズ,インコーポレイテッド | ナタリズマブを用いて炎症性疾患および自己免疫性疾患を治療する方法 |
KR20080104343A (ko) | 2006-03-03 | 2008-12-02 | 엘란 파마슈티칼스, 인크. | 나탈리주마브로 염증 및 자가면역 질환을 치료하는 방법 |
EP3349010A1 (en) | 2009-10-11 | 2018-07-18 | Biogen MA Inc. | Anti-vla-4 related assays |
HUE060312T2 (hu) | 2010-01-11 | 2023-02-28 | Biogen Ma Inc | A JC vírus antitestek vizsgálata |
US11287423B2 (en) | 2010-01-11 | 2022-03-29 | Biogen Ma Inc. | Assay for JC virus antibodies |
FI3575792T3 (fi) * | 2011-05-31 | 2023-03-17 | Pml-riskin arviointimenetelmä | |
US20150065367A1 (en) * | 2011-12-12 | 2015-03-05 | Janssen Diagnostics Bvba | Polyomavirus peptide sequences |
WO2013158674A1 (en) * | 2012-04-16 | 2013-10-24 | Board Of Regents, The University Of Texas System | Detection of extracellular jcv micrornas |
WO2013192100A1 (en) | 2012-06-18 | 2013-12-27 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Methods and compositions for detecting jc virus |
EP3517545A1 (en) * | 2012-12-31 | 2019-07-31 | Neurimmune Holding AG | Recombinant human antibodies for therapy and prevention of polyomavirus-related diseases |
US9949671B2 (en) | 2013-03-13 | 2018-04-24 | Orthoaccel Technologies, Inc. | Diagnostic mouthpieces |
EP3004334A4 (en) | 2013-05-28 | 2016-12-21 | Biogen Ma Inc | METHODS OF EVALUATION RISK OF DEVELOPMENT OF PML |
US10955422B2 (en) | 2014-02-27 | 2021-03-23 | Biogen Ma, Inc. | Method of assessing risk of PML |
MA40985A (fr) | 2014-11-17 | 2017-09-26 | Biogen Ma Inc | Méthodes de traitement de la sclérose en plaques |
IT201600083859A1 (it) * | 2016-08-09 | 2018-02-09 | Univ Degli Studi Di Ferrara | Immunosaggio per l’identificazione di anticorpi contro il virus Polioma JC (JCPyV) mediante l’uso di peptidi sintetici. |
WO2019169317A1 (en) * | 2018-03-02 | 2019-09-06 | Stueve Olaf | Methods and compositions for treating natalizumab-associated progressive multifocal encephalopathy |
Family Cites Families (95)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL154598B (nl) | 1970-11-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking. |
US3817837A (en) | 1971-05-14 | 1974-06-18 | Syva Corp | Enzyme amplification assay |
US3939350A (en) | 1974-04-29 | 1976-02-17 | Board Of Trustees Of The Leland Stanford Junior University | Fluorescent immunoassay employing total reflection for activation |
US3996345A (en) | 1974-08-12 | 1976-12-07 | Syva Company | Fluorescence quenching with immunological pairs in immunoassays |
US4275149A (en) | 1978-11-24 | 1981-06-23 | Syva Company | Macromolecular environment control in specific receptor assays |
US4277437A (en) | 1978-04-05 | 1981-07-07 | Syva Company | Kit for carrying out chemically induced fluorescence immunoassay |
US4235601A (en) | 1979-01-12 | 1980-11-25 | Thyroid Diagnostics, Inc. | Test device and method for its use |
US4391904A (en) | 1979-12-26 | 1983-07-05 | Syva Company | Test strip kits in immunoassays and compositions therein |
US4376110A (en) | 1980-08-04 | 1983-03-08 | Hybritech, Incorporated | Immunometric assays using monoclonal antibodies |
US4366241A (en) | 1980-08-07 | 1982-12-28 | Syva Company | Concentrating zone method in heterogeneous immunoassays |
US4517288A (en) | 1981-01-23 | 1985-05-14 | American Hospital Supply Corp. | Solid phase system for ligand assay |
US4703017C1 (en) | 1984-02-14 | 2001-12-04 | Becton Dickinson Co | Solid phase assay with visual readout |
CA1291031C (en) | 1985-12-23 | 1991-10-22 | Nikolaas C.J. De Jaeger | Method for the detection of specific binding agents and their correspondingbindable substances |
US5763262A (en) | 1986-09-18 | 1998-06-09 | Quidel Corporation | Immunodiagnostic device |
ES2050704T5 (es) | 1987-04-27 | 2004-04-16 | Inverness Medical Switzerland Gmbh | Inmunoensayos y dispositivos para su realizacion. |
US4943522A (en) | 1987-06-01 | 1990-07-24 | Quidel | Lateral flow, non-bibulous membrane assay protocols |
US5120643A (en) | 1987-07-13 | 1992-06-09 | Abbott Laboratories | Process for immunochromatography with colloidal particles |
US4818677A (en) | 1987-12-03 | 1989-04-04 | Monoclonal Antibodies, Inc. | Membrane assay using focused sample application |
AU2684488A (en) | 1988-06-27 | 1990-01-04 | Carter-Wallace, Inc. | Test device and method for colored particle immunoassay |
US5221616A (en) | 1988-07-15 | 1993-06-22 | Quidel Corporation | Prevention of spontaneous complement activation in mammalian biological fluids |
US5118630A (en) | 1988-11-04 | 1992-06-02 | Quidel Corporation | Method for determining periodic infertility in females |
US6352862B1 (en) | 1989-02-17 | 2002-03-05 | Unilever Patent Holdings B.V. | Analytical test device for imuno assays and methods of using same |
US6033665A (en) | 1989-09-27 | 2000-03-07 | Elan Pharmaceuticals, Inc. | Compositions and methods for modulating leukocyte adhesion to brain endothelial cells |
US5084828A (en) | 1989-09-29 | 1992-01-28 | Healthtech Services Corp. | Interactive medication delivery system |
US5252496A (en) | 1989-12-18 | 1993-10-12 | Princeton Biomeditech Corporation | Carbon black immunochemical label |
US5096837A (en) | 1990-02-08 | 1992-03-17 | Pacific Biotech, Inc. | Immunochromatographic assay and method of using same |
US5223220A (en) | 1990-03-27 | 1993-06-29 | Pacific Biotech, Inc. | Solid phase immunoassay device and method of making same |
US5118428A (en) | 1990-11-13 | 1992-06-02 | Quidel | Method to remove red blood cells from whole blood samples |
DE4139840B4 (de) | 1990-12-04 | 2005-06-02 | Quidel Corp., San Diego | Antigen-Zubereitung zum Nachweis von H. pylori |
WO1992012428A1 (en) | 1991-01-11 | 1992-07-23 | Quidel Corporation | A one-step lateral flow nonbibulous assay |
US5213796A (en) | 1991-05-06 | 1993-05-25 | Dana Farber Cancer Institute | Assay for polyomavirus in humans and uses thereof |
US5225328A (en) | 1991-05-30 | 1993-07-06 | Quidel Corporation | Stable alkaline phosphatase compositions with color enhancement and their use in assays |
US5686315A (en) | 1991-06-14 | 1997-11-11 | Quidel Corporation | Assay device for one step detection of analyte |
WO1993015217A1 (en) | 1992-02-04 | 1993-08-05 | Quidel Corporation | Simplified extraction method for bacterial antigens using dried reagents |
US5541069A (en) | 1992-02-28 | 1996-07-30 | Quidel Corporation | Assay having improved dose response curve |
ES2151902T3 (es) | 1992-03-10 | 2001-01-16 | Quidel Corp | Medio de separacion de globulos rojos para dosificarlos mediante union especifica. |
DK0678122T3 (da) | 1993-01-12 | 2000-03-06 | Biogen Inc | Rekombinante anti-VLA4 antistofmolekyler |
US5415994A (en) | 1993-08-02 | 1995-05-16 | Quidel Corporation | Lateral flow medical diagnostic assay device with sample extraction means |
US5840299A (en) | 1994-01-25 | 1998-11-24 | Athena Neurosciences, Inc. | Humanized antibodies against leukocyte adhesion molecule VLA-4 |
US5434057A (en) | 1994-02-02 | 1995-07-18 | Quidel Corporation | Sperm motility assay and devices |
US5521102A (en) | 1994-08-08 | 1996-05-28 | Quidel Corporation | Controlled sensitivity immunochromatographic assay |
US5845255A (en) | 1994-10-28 | 1998-12-01 | Advanced Health Med-E-Systems Corporation | Prescription management system |
US6551593B1 (en) | 1995-02-10 | 2003-04-22 | Millennium Pharmaceuticals, Inc. | Treatment of Inflammatory bowel disease by inhibiting binding and/or signalling through α 4 β 7 and its ligands and madcam |
US5712172A (en) | 1995-05-18 | 1998-01-27 | Wyntek Diagnostics, Inc. | One step immunochromatographic device and method of use |
US5804452A (en) | 1995-04-27 | 1998-09-08 | Quidel Corporation | One step urine creatinine assays |
US5786220A (en) | 1995-04-28 | 1998-07-28 | Quidel Corporation | Assays and devices for distinguishing between normal and abnormal pregnancy |
US20010051350A1 (en) | 1995-05-02 | 2001-12-13 | Albert Nazareth | Diagnostic detection device and method |
US5773234A (en) | 1995-08-07 | 1998-06-30 | Quidel Corporation | Method and device for chlamydia detection |
DE19543553B4 (de) | 1995-11-22 | 2009-04-09 | Deutsches Primatenzentrum Gmbh | VP-Antigene des JC-Virus |
US6305377B1 (en) | 1996-12-12 | 2001-10-23 | Michael T. Portwood | System and method for improving compliance of a medical regimen |
US6229011B1 (en) | 1997-08-22 | 2001-05-08 | Hoffman-La Roche Inc. | N-aroylphenylalanine derivative VCAM-1 inhibitors |
US6306642B1 (en) | 1997-11-24 | 2001-10-23 | Quidel Corporation | Enzyme substrate delivery and product registration in one step enzyme immunoassays |
US6623981B2 (en) | 1998-01-27 | 2003-09-23 | Bristol-Myers Squibb Company | Detection of patients at risk for developing integrin antagonist/agonist mediated disease states |
US6014631A (en) | 1998-04-02 | 2000-01-11 | Merck-Medco Managed Care, Llc | Computer implemented patient medication review system and process for the managed care, health care and/or pharmacy industry |
US6045501A (en) | 1998-08-28 | 2000-04-04 | Celgene Corporation | Methods for delivering a drug to a patient while preventing the exposure of a foetus or other contraindicated individual to the drug |
US6407066B1 (en) | 1999-01-26 | 2002-06-18 | Elan Pharmaceuticals, Inc. | Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by VLA-4 |
US7171371B2 (en) | 1999-09-03 | 2007-01-30 | Smg Trust | Method and system for providing pre and post operative support and care |
TR200201006T2 (tr) | 1999-10-12 | 2002-11-21 | Connex Gesellschaft Zur Optimierung Von Forschung Und | Dışkıda bulunan aside dirençli mikroorganizmaların tespitine ilişkin geliştirilmiş yöntem. |
US6388084B1 (en) | 1999-12-06 | 2002-05-14 | Hoffmann-La Roche Inc. | 4-pyridinyl-n-acyl-l-phenylalanines |
JP2003517023A (ja) | 1999-12-16 | 2003-05-20 | バイオジェン インコーポレイテッド | 中枢神経系の虚血性損傷または出血性損傷を、抗α4インテグリンアンタゴニストを用いて処置する方法 |
AU4465001A (en) | 2000-03-30 | 2001-10-15 | Nippon Kayaku Kabushiki Kaisha | Method of examining cancer by assaying autoantibody against mdm2 and reagent therefor |
US6620626B1 (en) | 2000-08-09 | 2003-09-16 | Mission Research Corp. | Antigen detection device and method |
MY129000A (en) | 2000-08-31 | 2007-03-30 | Tanabe Seiyaku Co | INHIBITORS OF a4 MEDIATED CELL ADHESION |
AU2002210384B2 (en) | 2000-10-17 | 2006-10-19 | Besst-Test Aps | Assay for directly detecting a RS virus related biological cell in a body fluid sample |
US6315720B1 (en) | 2000-10-23 | 2001-11-13 | Celgene Corporation | Methods for delivering a drug to a patient while avoiding the occurrence of an adverse side effect known or suspected of being caused by the drug |
US6485460B2 (en) | 2001-01-12 | 2002-11-26 | Bracco Diagnostics, Inc. | Tamper evident syringe barrel |
WO2003016902A1 (en) | 2001-08-20 | 2003-02-27 | Proteome Systems Intellectual Property Pty Ltd | Diagnostic testing process and apparatus |
ATE539816T1 (de) | 2001-08-20 | 2012-01-15 | Proteome Systems Ltd | Verfahren zum diagnostischen testen |
US6605602B1 (en) | 2001-09-28 | 2003-08-12 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Method of treating BK virus nephropathy |
ATE512163T1 (de) | 2002-02-25 | 2011-06-15 | Elan Pharm Inc | Verabreichung von mitteln zur behandlung von entzündungen |
TWI281470B (en) | 2002-05-24 | 2007-05-21 | Elan Pharm Inc | Heterocyclic compounds which inhibit leukocyte adhesion mediated by alpha4 integrins |
TW200307671A (en) | 2002-05-24 | 2003-12-16 | Elan Pharm Inc | Heteroaryl compounds which inhibit leukocyte adhesion mediated by α 4 integrins |
WO2004001539A2 (en) | 2002-06-21 | 2003-12-31 | Mckesson Information Solutions Llc | Closed loop medication use system and method |
US20070275481A1 (en) | 2003-11-24 | 2007-11-29 | Biogen Idec Ma Inc. | Methods For Detecting Half-Antibodies Using Chip Based Gel Electophoresis |
JP4672263B2 (ja) | 2004-01-27 | 2011-04-20 | デンカ生研株式会社 | 簡便な検出法、検出装置及び検出キットとその製法 |
US7419666B1 (en) | 2004-02-23 | 2008-09-02 | Massachusetts Eye And Ear Infirmary | Treatment of ocular disorders |
TWI556829B (zh) | 2004-04-09 | 2016-11-11 | 艾伯維生物技術有限責任公司 | 用於治療TNFα相關失調症之多重可變劑量療法 |
US20050283385A1 (en) | 2004-06-21 | 2005-12-22 | The Permanente Medical Group, Inc. | Individualized healthcare management system |
CN101035563B (zh) | 2004-07-08 | 2012-03-28 | 艾伦药物公司 | 包括聚合物部分的多价vla-4拮抗剂 |
CA2478458A1 (en) | 2004-08-20 | 2006-02-20 | Michael Panzara | Treatment of pediatric multiple sclerosis |
EP1833509A4 (en) | 2004-12-03 | 2008-12-03 | Biogen Idec Inc | DELAYING OR PREVENTING THE APPEARANCE OF MULTIPLE SCLEROSIS |
ES2387317T3 (es) | 2005-03-03 | 2012-09-20 | Seedlings Life Science Ventures, Llc. | Procedimiento de control de riesgos de pacientes en tratamiento con natalizumab |
PL3264094T3 (pl) | 2005-04-04 | 2021-04-19 | Biogen Ma Inc. | Sposoby oceniania odpowiedzi immunologicznej na środek leczniczy |
WO2007041270A1 (en) | 2005-09-29 | 2007-04-12 | Elan Pharmaceuticals, Inc. | Pyrimidinyl amide compounds which inhibit leukocyte adhesion mediated by vla-4 |
CA2643838A1 (en) | 2006-02-27 | 2007-09-07 | Elan Pharmaceuticals, Inc. | Pyrimidinyl sulfonamide compounds which inhibit leukocyte adhesion mediated by vla-4 |
JP2009528359A (ja) | 2006-02-28 | 2009-08-06 | エラン ファーマシューティカルズ,インコーポレイテッド | ナタリズマブを用いて炎症性疾患および自己免疫性疾患を治療する方法 |
WO2007100763A2 (en) | 2006-02-28 | 2007-09-07 | Elan Pharmaceuticals, Inc. | Methods of treating inflammatory and autoimmune diseases with alpha-4 inhibitory compounds |
KR20080104343A (ko) | 2006-03-03 | 2008-12-02 | 엘란 파마슈티칼스, 인크. | 나탈리주마브로 염증 및 자가면역 질환을 치료하는 방법 |
US7838583B2 (en) * | 2006-06-30 | 2010-11-23 | Sumitomo Rubber Industries, Ltd. | Rubber composition for cap tread and pneumatic tire having cap tread using same |
EP2089515A4 (en) | 2006-11-16 | 2011-02-23 | Novavax Inc | VIRUSUAL PARTICLES OF RESPIRATORY SYNZYTIAL VIRUS |
EP1933140B1 (en) | 2006-12-11 | 2011-08-17 | AraGen Biotechnology Co. Ltd. | Antibody detection method involving an oligonucleotide enhanced collodial gold signal |
CN104316696A (zh) | 2009-02-05 | 2015-01-28 | 生物基因Idecma公司 | 用于检测jc多瘤病毒的方法 |
CN102326080B (zh) | 2009-02-20 | 2015-08-05 | 加利福尼亚大学董事会 | A+生物标志物的试验 |
HUE060312T2 (hu) | 2010-01-11 | 2023-02-28 | Biogen Ma Inc | A JC vírus antitestek vizsgálata |
FI3575792T3 (fi) | 2011-05-31 | 2023-03-17 | Pml-riskin arviointimenetelmä |
-
2011
- 2011-01-11 HU HUE17203178A patent/HUE060312T2/hu unknown
- 2011-01-11 PL PL17203178.3T patent/PL3339865T3/pl unknown
- 2011-01-11 LT LTEP11732315.4T patent/LT2524060T/lt unknown
- 2011-01-11 NZ NZ600681A patent/NZ600681A/en unknown
- 2011-01-11 CA CA2784137A patent/CA2784137A1/en active Pending
- 2011-01-11 WO PCT/US2011/020832 patent/WO2011085369A1/en active Application Filing
- 2011-01-11 EP EP22191259.5A patent/EP4152004A1/en active Pending
- 2011-01-11 SI SI201132069T patent/SI3339865T1/sl unknown
- 2011-01-11 AU AU2011203815A patent/AU2011203815B2/en active Active
- 2011-01-11 MX MX2012007660A patent/MX341991B/es active IP Right Grant
- 2011-01-11 ME MEP-2018-60A patent/ME03026B/me unknown
- 2011-01-11 NO NO11732315A patent/NO2524060T3/no unknown
- 2011-01-11 DK DK17203178.3T patent/DK3339865T5/da active
- 2011-01-11 RS RS20221053A patent/RS63744B1/sr unknown
- 2011-01-11 DK DK11732315.4T patent/DK2524060T3/en active
- 2011-01-11 RS RS20180245A patent/RS56977B1/sr unknown
- 2011-01-11 PL PL11732315T patent/PL2524060T3/pl unknown
- 2011-01-11 BR BR112012017014-7A patent/BR112012017014B1/pt active IP Right Grant
- 2011-01-11 KR KR1020127019171A patent/KR101877576B1/ko active IP Right Grant
- 2011-01-11 FI FIEP17203178.3T patent/FI3339865T5/fi active
- 2011-01-11 LT LTEP17203178.3T patent/LT3339865T/lt unknown
- 2011-01-11 SI SI201131438T patent/SI2524060T1/en unknown
- 2011-01-11 ES ES17203178T patent/ES2930469T3/es active Active
- 2011-01-11 JP JP2012548227A patent/JP5946218B2/ja active Active
- 2011-01-11 PT PT117323154T patent/PT2524060T/pt unknown
- 2011-01-11 SG SG2012043154A patent/SG181653A1/en unknown
- 2011-01-11 CN CN2011800133864A patent/CN102906278A/zh active Pending
- 2011-01-11 PT PT172031783T patent/PT3339865T/pt unknown
- 2011-01-11 EP EP17203178.3A patent/EP3339865B9/en active Active
- 2011-01-11 HU HUE11732315A patent/HUE036183T2/hu unknown
- 2011-01-11 HR HRP20221390TT patent/HRP20221390T1/hr unknown
- 2011-01-11 EP EP11732315.4A patent/EP2524060B1/en not_active Revoked
- 2011-01-11 SG SG10201500079YA patent/SG10201500079YA/en unknown
- 2011-01-11 ES ES11732315.4T patent/ES2664173T3/es active Active
- 2011-01-11 IN IN6139DEN2012 patent/IN2012DN06139A/en unknown
- 2011-01-11 US US13/521,311 patent/US9316641B2/en active Active
-
2015
- 2015-12-18 JP JP2015246985A patent/JP2016040557A/ja not_active Withdrawn
-
2016
- 2016-03-08 US US15/063,777 patent/US10444234B2/en active Active
-
2018
- 2018-02-27 HR HRP20180356TT patent/HRP20180356T1/hr unknown
- 2018-02-28 CY CY20181100251T patent/CY1119972T1/el unknown
- 2018-11-13 HK HK18114454.0A patent/HK1255318A1/zh unknown
-
2022
- 2022-11-18 CY CY20221100739T patent/CY1126069T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1119972T1 (el) | Προσδιορισμος για αντισωματα ιου jc | |
CY1121291T1 (el) | Ανοσοδοκιμασιες ενισχυσης σηματος | |
EA201171046A1 (ru) | Зонды и праймеры для детектирования вируса чикунгуньи | |
BR112018000851A2 (pt) | sistemas e métodos para detecção e quantificação aprimoradas de analitos | |
WO2015070037A3 (en) | Polynucleotide conjugates and methods for analyte detection | |
ATE436015T1 (de) | Verfahren, chip, vorrichtung und integriertes system zum nachweis biologischer partikel | |
ATE556030T1 (de) | Ultrasensitiver nachweis von analyten | |
MX349288B (es) | Sistemas y metodos para maximizacion de uso de muestras. | |
DE602005020978D1 (de) | Optoelektronisches detektionssystem | |
EA200971114A1 (ru) | Определение антигенов, расположенных на эритроцитах, и антиэритроцитарных антител | |
EP2583100A4 (en) | ROTORS FOR IMMUNOASSAYS | |
DK2791675T3 (da) | Måling af autoantistoffer under lav ledeevne-betingelser | |
JP2014533372A5 (el) | ||
MX2019006098A (es) | Ensayo de anticuerpos. | |
TR201819546T4 (tr) | Numune tür kökeni için tespit yöntemleri. | |
WO2011137388A3 (en) | Identification and use of biomarkers for detection and quantification of the level of radiation exposure in a biological sample | |
EA201500377A1 (ru) | Способ обнаружения анализируемого вещества и определение его концентрации с использованием намагничиваемых гранул | |
CY1113013T1 (el) | Βελτιωμενες μεθοδοι ανοσολογικων δοκιμασιων | |
MX347049B (es) | Dispositivo de prueba. | |
EA201400356A1 (ru) | Иммуноанализ для обнаружения антибиотиков | |
BR112017010180A2 (pt) | dispositivos e métodos para detecção de norovírus em superfícies | |
MX2016013429A (es) | Dispositivo y metodo para detectar antigenos de grupo sanguineo por medio de un anticuerpo incompleto. | |
DK1991875T3 (da) | Test til påvisning af patologiske prioner | |
EA201401097A1 (ru) | Способ оценки жизнеспособности вирусов, обладающих лимфотропизмом | |
WO2012068107A3 (en) | Autoantibody to rna-protein complex detected by quantitative pcr |